▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #786 by analyst upside · 2026-10-16
CELC
Celcuity Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+160.2%
implied upside to consensus target
Current Price $60.3
Consensus Target $156.91
Bull Target $177.0
Bear Target $130.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
8
Hold
0
Sell
0
52-Week Low $49.8
52-Week High $151.02
YTD Return -40.0%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-4.09
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $49.8
52-Week High $151.02
Current Price $60.3
Bear Target $130.0
Bull Target $177.0
● Now $60.3 ● Target $156.91
TRADING DATA
Avg Volume 1.1M
YTD Return -40.0%
Analyst Count 11
Consensus Buy
Upside to Target +160.2%
Last Updated 2026-10-16

ANALYST SUMMARY

Celcuity Inc. (CELC) is currently trading at $60.3 with a Wall Street consensus price target of $156.91, implying potential upside of 160.2% over the next 12 months. 11 analysts currently cover CELC, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $177.0, while the most cautious has a target of $130.0.

CELC operates in the Healthcare sector with a market capitalisation of $3B. The stock is down 40.0% year-to-date and is currently trading near the lower end of its 52-week range of $49.8 – $151.02.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CELC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Needham - Reiterated
Buy → Buy 2026-09-30 20% win rate (5 calls)
JP Morgan ● Initiated
Overweight 2026-09-17 43% win rate (7 calls)
Guggenheim - Reiterated
Buy → Buy 2026-08-17 62% win rate (8 calls)
Citizens reit
Market Outperform → Market Outperform 2026-08-17 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-08-14 31% win rate (48 calls)
Stifel - Reiterated
Buy → Buy 2026-08-14 Building track record
Needham - Reiterated
Buy → Buy 2026-08-14 20% win rate (5 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-07-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
19/30
Consensus clarity
14/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →